| 1 |
34643035 | The modification of the thrombin generation assay for the clinical assessment of hypercoagulability in patients receiving heparin therapy. | 2022 Apr |
3 |
| 2 |
34871836 | The heparinase-linked differential time method allows detection of heparin potency in whole blood with high sensitivity and dynamic range. | 2022 Feb 15 |
2 |
| 3 |
35021888 | Combining Heparin and a FX/Xa Aptamer to Reduce Thrombin Generation in Cardiopulmonary Bypass and COVID-19. | 2022 Jun |
2 |
| 4 |
35038779 | Measurement of procoagulant platelets provides mechanistic insight and diagnostic potential in heparin-induced thrombocytopenia. | 2022 Apr |
1 |
| 5 |
35185059 | A Case of Atrial Fibrillation in a Patient with Heparin-induced Thrombocytopenia Successfully Treated by Radiofrequency Catheter Ablation Using a Direct Thrombin Inhibitor. | 2022 Feb 19 |
1 |
| 6 |
35582539 | Potential mechanisms of resistance to current anti-thrombotic strategies in Multiple Myeloma. | 2022 |
1 |
| 7 |
31645190 | Argatroban Versus Bivalirudin in the Treatment of Suspected or Confirmed Heparin-Induced Thrombocytopenia. | 2021 Aug |
1 |
| 8 |
33176060 | Skeletal muscle myosin and cardiac myosin attenuate heparin's antithrombin-dependent anticoagulant activity. | 2021 Feb |
3 |
| 9 |
33202269 | A Heparin based dual ratiometric sensor for Thrombin. | 2021 Jan 15 |
4 |
| 10 |
33618796 | Correction to the article "Viscoelastic Tests in the Evaluation of Haemostatic Disorders in SARS-CoV-2 Infection", Published on Acta Med Port 2021 Jan;34(1):35-46. | 2021 Jan 4 |
2 |
| 11 |
33725411 | Heparins have adequate ex vivo anticoagulant effects in hospitalized patients with cirrhosis. | 2021 Jun |
1 |
| 12 |
33805059 | A Combined Activity of Thrombin and P-Selectin Is Essential for Platelet Activation by Pancreatic Cancer Cells. | 2021 Mar 24 |
1 |
| 13 |
33846433 | Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study. | 2021 Apr 12 |
1 |
| 14 |
33860518 | Factor XI as a Target for New Anticoagulants. | 2021 Apr |
1 |
| 15 |
33910609 | Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study. | 2021 Apr 29 |
2 |
| 16 |
33929278 | Clot activators and anticoagulant additives for blood collection. A critical review on behalf of COLABIOCLI WG-PRE-LATAM. | 2021 May |
2 |
| 17 |
33968948 | The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19. | 2021 |
1 |
| 18 |
34413778 | Bivalirudin Attenuates Thrombin-Induced Endothelial Hyperpermeability via S1P/S1PR2 Category: Original Articles. | 2021 |
2 |
| 19 |
34569328 | Low-Molecular-Weight Heparin Anti-Xa Guided Reversal of Apixaban With Prothrombin Complex Concentrate in a Patient on Hemodialysis. | 2021 Sep 25 |
1 |
| 20 |
34660719 | Effects of Heparin and Bivalirudin on Thrombin-Induced Platelet Activation: Differential Modulation of PAR Signaling Drives Divergent Prothrombotic Responses. | 2021 |
3 |
| 21 |
34677453 | Chemical Structure and Anticoagulant Property of a Novel Sulfated Polysaccharide from the Green Alga Cladophora oligoclada. | 2021 Sep 29 |
1 |
| 22 |
34743814 | SARS-CoV-2 spike protein causes blood coagulation and thrombosis by competitive binding to heparan sulfate. | 2021 Dec 15 |
2 |
| 23 |
31471127 | From unfractionated heparin to pentasaccharide: Paradigm of rigorous science growing in the understanding of the in vivo thrombin generation. | 2020 Jan |
1 |
| 24 |
31559512 | Evaluation of intravenous direct thrombin inhibitor monitoring tests: Correlation with plasma concentrations and clinical outcomes in hospitalized patients. | 2020 Feb |
1 |
| 25 |
31686597 | The mechanism of high affinity pentasaccharide binding to antithrombin, insights from Gaussian accelerated molecular dynamics simulations. | 2020 Oct |
2 |
| 26 |
32000579 | Syndecan-4 Protects the Heart From the Profibrotic Effects of Thrombin-Cleaved Osteopontin. | 2020 Feb 4 |
1 |
| 27 |
32088260 | Pentosan polysulfate to control hepcidin expression in vitro and in vivo. | 2020 May |
1 |
| 28 |
32127275 | Heparin Dose and Point-of-Care Measurements of Hemostasis in Cardiac Surgery-Results of a Randomized Controlled Trial. | 2020 Sep |
3 |
| 29 |
32292283 | Simple thrombin-based method for eliminating fibrinogen interference in serum protein electrophoresis of haemodialysed patients. | 2020 Jun 15 |
1 |
| 30 |
32422680 | Thr90Ser Mutation in Antithrombin is Associated with Recurrent Thrombosis in a Heterozygous Carrier. | 2020 Jul |
1 |
| 31 |
32544388 | Modeling Thrombin Generation in Plasma under Diffusion and Flow. | 2020 Jul 7 |
2 |
| 32 |
32550069 | Anticoagulation Options for Coronavirus Disease 2019 (COVID-19)-Induced Coagulopathy. | 2020 May 16 |
2 |
| 33 |
32576355 | [A real-world study of low molecular weight heparin sodium in the treatment of severe and critical bite by Trimeresurus stejnegeri]. | 2020 May |
1 |
| 34 |
32668058 | Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis. | 2020 Sep |
1 |
| 35 |
32668719 | A Novel C1-Esterase Inhibitor Oxygenator Coating Prevents FXII Activation in Human Blood. | 2020 Jul 13 |
1 |
| 36 |
32779783 | Effect of low or high doses of low-molecular-weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID-19. | 2020 Aug |
1 |
| 37 |
32905282 | SARS-CoV-2 and pulmonary embolism: who stole the platelets? | 2020 |
1 |
| 38 |
33030036 | Comparative Anticoagulant and Thrombin Generation Inhibitory Profile of Heparin, Sulodexide and Its Components. | 2020 Jan-Dec |
2 |
| 39 |
30407650 | Plasma exchange for heparin-induced thrombocytopenia in patients on extracorporeal circuits: A challenging case and a survey of the field. | 2019 Feb |
1 |
| 40 |
30543545 | Direct-Thrombin Inhibitor Utilization in Patients With Heparin-Induced Thrombocytopenia and Undergoing Catheter-Directed Thrombolysis: A Summary of Published Case Reports. | 2019 May/Jun |
1 |
| 41 |
30573233 | A new approach for membrane modification based on electrochemically mediated living polymerization and self-assembly of N-tert-butyl amide- and β-cyclodextrin-involved macromolecules for blood purification. | 2019 Feb 1 |
1 |
| 42 |
30713119 | Anticoagulant activity of enoxaparin and unfractionated heparin for venous thromboembolism prophylaxis in obese patients undergoing sleeve gastrectomy. | 2019 Mar |
1 |
| 43 |
30714261 | Recent achievements and future developments in neonatal cardiopulmonary bypass. | 2019 May |
1 |
| 44 |
30725510 | Sodium-site in serine protease domain of human coagulation factor IXa: evidence from the crystal structure and molecular dynamics simulations study. | 2019 Apr |
3 |
| 45 |
30727756 | Selective Inhibition of PAR4 (Protease-Activated Receptor 4)-Mediated Platelet Activation by a Synthetic Nonanticoagulant Heparin Analog. | 2019 Apr |
3 |
| 46 |
30793294 | Effect of heparin thromboprophylaxis on thrombin generation in multiple myeloma patients. | 2019 Jul |
1 |
| 47 |
30850576 | Autoimmune Heparin-Induced Thrombocytopenia: Treatment Obstacles and Challenging Length of Stay. | 2019 Mar 9 |
1 |
| 48 |
30869126 | Recombinant dermatan sulfate is a potent activator of heparin cofactor II-dependent inhibition of thrombin. | 2019 Jun 1 |
3 |
| 49 |
30907752 | Titration of Bivalirudin Infusion in the Pediatric Cardiac Catheterization Laboratory: A Case Report. | 2019 Jul 15 |
1 |
| 50 |
30936586 | Microfluidic Point-of-Care Ecarin-Based Clotting and Chromogenic Assays for Monitoring Direct Thrombin Inhibitors. | 2019 Mar |
1 |